👋 G’day
Today’s brief:
Firms slash support staff and grads
Anthropic targets the legal AI layer
Fed budget hits investors hard
Here’s your latest, PB #{{join_number}} 👇
WORD ON THE STREET

The AI cull

A&O Shearman just axed 20 London business services roles across finance, marketing and IT. The global firm joins Clifford Chance, Freshfields and Baker McKenzie in quietly culling support staff as AI absorbs the work. In Australia, law firms are opting to take out tomorrow’s lawyers instead, with grad intakes down across the top tiers: Point Blank
Anthropic just launched Claude for Legal, plugging into Thomson Reuters, LexisNexis, Harvey, Legora, iManage and a stack of others. The play: make Claude the central AI layer lawyers work from, with everything else feeding in. Freshfields is already all-in: Artificial Lawyer
A former administrator is suing MinterEllison for $766k. She alleged she was called "slow" in group emails, told she'd "ruined everyone's Christmas mood," and bullied via caps lock and underlining. Minters says those emails were "innocuous" and she was also repeatedly complained about by colleagues: Lawyerly
PRACTICE POINTS

Whistleblower protections
⚖️ Employment/Compliance: The Full Federal Court has handed down the first appellate judgment on the post-2019 private sector whistleblower protections in Reiche, dismissing the appellant's compensation claim and clarifying when detrimental conduct actually triggers liability. The Court confirmed four elements must all be satisfied: (1)the alleged wrongdoer must have subjectively believed or suspected a disclosure was made or could be made, (2) that it concerned misconduct or an improper state of affairs, (3) that the whistleblower had reasonable grounds, and (4) that belief was the substantial and operative reason for the detrimental conduct. Critically, the reverse onus means decision-makers need documented reasons for any adverse action touching a potential whistleblower. Mallesons
⚖️ Capital Markets: From 4 December 2026, cash-settled equity derivatives will be captured by Australia's substantial holding regime through the new "deemed economic interest" concept. The regime requires daily recalculation of derivative-based positions, disclosure triggered by movements exceeding 1%, and lodgement within two business days. And, short positions can't be netted against long exposures when assessing whether thresholds are crossed. Exemptions exist for market makers and client-facing AFS licensees: Ashurst
⚖️ Construction/Regulatory: Victoria's amended Security of Payment Act commenced on 15 April 2026, introducing a statutory mechanism for contractors to claim the return of performance security for the first time. Contractors can now serve a claim for the release of cash retention or bank guarantees, with the window to do so opening no earlier than 20 business days after the defects liability period expires and closing at the end of the following month, which can produce a window as narrow as two business days. Principals must now give at least five business days' notice before calling on security, and any 'no injunction' or notice-waiver clauses are void: Holding Redlich
TALKING POINTS

Budget breakdown

Did you hear…
Chalmers just handed investors a rude awakening. The 50% CGT discount is gone, replaced with inflation indexation and a 30% minimum rate. Negative gearing gets quarantined to new builds only. Treasury reckons the changes will cool house price growth by 2%. The whole package raises north of $7bn a year. The proceeds partly fund a $250 tax offset for 13 million wage earners: AFR
Also…
Gina Rinehart has appealed last month's Supreme Court decision ordering Hancock Prospecting to pay hundreds of millions in royalties to Wright Prospecting and DFD Rhodes. No surprise there — with an estimated $150m already spent, 34 barristers on the judgment, and billions in East Angelas iron ore still in play, nobody's walking away: The Australian
DEAL ROOM

Insignia battle
🙅 CC Capital finally closed its $3.3bn grab of Insignia Financial, after eight bids, three suitors and a nearly 18-month saga. Mallesons acted for Insignia (Peter Stirling, Genovieve Lajeunesse); Ashurst advised the buyer (Anton Harris, Will Mason). Speculation's already swirling over a tilt at AMP. Read our full deep dive: Point Blank
🏥 Qscan, Infratil's $400m Australian radiology group, has drawn a surprise new bidder. London-based infrastructure specialist InfraRed Capital Partners has been shortlisted by sell-side adviser UBS, joining Pacific Equity Partners (advised by Rothschild) and Bain Capital in the race: AFR
🎮 eBay's board has told GameStop where to go, rejecting its unsolicited $56bn takeover bid as "neither credible nor attractive." Chairman Paul Pressler cited financing uncertainty and operational risks of a combined entity: The Australian
SECTOR SNAPSHOT

Fatal advice


DIGGERS
🚜 Fortescue has been ordered to pay $150.1m to the Yindjibarndi people for mining their ancestral lands without consent. That’s all while the Forrest family pocketed $16.9bn in dividends from the Solomon Hub over 13.5 years: AFR

FIN
🏦 CBA posted a $2.7bn quarterly cash profit, down 1% on the half but up 4% on the prior quarter. Loan impairment hit $316m, with collective provisions lifted on geopolitical jitters. Margins held steady, expenses crept up on cloud and AI spend, and CEO Matt Comyn says the economy's resilient but headwinds loom: The Australian

RETAIL + REAL ESTATE
🏠 Altus Property Group's Gold Coast Trump tower is dead, with the Trump Organisation pulling the plug after developer David Young allegedly failed to meet licensing obligations. Young's pushing back, blaming the Trump brand's toxicity in Australia, and insisting the 91-storey project can live on under a different luxury brand: AFR

TECH + STARTUPS
📱 OpenAI is facing a wrongful death suit after ChatGPT allegedly recommended a fatal drug combination to a college student, who died following the dosing advice. Claims include defective design, negligence and unlicensed medical practice. The family wants damages plus an injunction to pause OpenAI's healthcare-related products: Bloomberg
P.S.

